{
  "paper_id": "PMC9837649",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837649/",
  "figures": {
    "figure_0005": {
      "figure_number": "Figure 0005",
      "title": "Figure 1.",
      "caption": "Leukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/b92bd027c696/gr1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/b92bd027c696/gr1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/b92bd027c696/gr1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/b92bd027c696/gr1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig0005",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/b92bd027c696/gr1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9837649/images/figure_0005.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/b92bd027c696/gr1.jpg"
    },
    "figure_0010": {
      "figure_number": "Figure 0010",
      "title": "Figure 2.",
      "caption": "Leukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/1b5905ec6086/gr2.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/1b5905ec6086/gr2.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/1b5905ec6086/gr2.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/1b5905ec6086/gr2.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig0010",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/1b5905ec6086/gr2.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9837649/images/figure_0010.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/1b5905ec6086/gr2.jpg"
    },
    "figure_0015": {
      "figure_number": "Figure 0015",
      "title": "Figure 3.",
      "caption": "Leukemia cutis in a patient with AML. (A) Post-allogeneic BMT recurrence – two isolated erythematous, smooth, hardened papules on both thighs. (B), Detail of the lesion at higher magnification.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/65e6148f446e/gr3.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/65e6148f446e/gr3.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/65e6148f446e/gr3.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/65e6148f446e/gr3.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig0015",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/65e6148f446e/gr3.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9837649/images/figure_0015.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/65e6148f446e/gr3.jpg"
    },
    "figure_0020": {
      "figure_number": "Figure 0020",
      "title": "Figure 4.",
      "caption": "Cutaneous plasmacytoma. Erythematous-violaceous nodules, poorly defined and infiltrated in the periumbilical region.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/5bea78245d8c/gr4.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/5bea78245d8c/gr4.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/5bea78245d8c/gr4.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/5bea78245d8c/gr4.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig0020",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/5bea78245d8c/gr4.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9837649/images/figure_0020.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/5bea78245d8c/gr4.jpg"
    },
    "figure_0025": {
      "figure_number": "Figure 0025",
      "title": "Figure 5.",
      "caption": "Secondary cutaneous follicular lymphoma. (A) Brownish-erythematous, infiltrated subcutaneous tumor, with telangiectasias in the epigastric region. (B) Lesion at higher magnification.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/11b7f24f75aa/gr5.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/11b7f24f75aa/gr5.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/11b7f24f75aa/gr5.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/11b7f24f75aa/gr5.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig0025",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/11b7f24f75aa/gr5.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9837649/images/figure_0025.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/11b7f24f75aa/gr5.jpg"
    },
    "figure_0030": {
      "figure_number": "Figure 0030",
      "title": "Figure 6.",
      "caption": "Secondary cutaneous CD30+ anaplastic lymphoma – erythematous, infiltrated, raised, reddish plaque in the central portion on the posterior right axillary line.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/020de8b3ed90/gr6.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/020de8b3ed90/gr6.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/020de8b3ed90/gr6.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/020de8b3ed90/gr6.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig0030",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/020de8b3ed90/gr6.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9837649/images/figure_0030.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a8/9837649/020de8b3ed90/gr6.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The role of cytogenetic alterations related to this type of tumor is also being studied.2, 6, 11\nClinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In CLL, specific cutaneous lesions appear in the later stages of the disease, approximately 40 months after the first systemic manifestations.15, 16\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML. (A), Multiple erythematous, infiltrated papules and nodules with a smooth surface affecting the trunk and upper limb. (B) Lesions at higher magnification.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Open in a new tab\nLeukemia cutis in a patient with AML ‒ confluent purpuric papules and some isolated ones with a rough surface on the lateral aspect of the left arm.Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Clinically, the lesions are not pathognomonic, as they are polymorphic, single or, mainly, multiple (Fig. 1).7, 10 The disease does not have a preferred location, despite being more commonly described on the trunk, extremities, and face,6, 8 but it is rarely seen in the palmoplantar region.3 Some authors mention that the infiltration occurs preferentially in sites with previous skin inflammation or infection.8, 14, 16 Lesion morphology does not allows the diagnosis of the involved cell line.2, 3, 6 They present as nodules, plaques and papules of varied consistency, are usually firm, of various sizes, and are brownish, erythematous, and/or violaceous, often purpuric in color (Fig. 2) due to the accompanying thrombocytopenia.2, 4 The surface is usually smooth, (Fig. 3), but erosions, ulcerations, and the presence of desquamation are sometimes observed.3 Other clinical presentations of leukemia cutis are very rare, such as maculopapular exanthema, exfoliative erythroderma, and single, rarely multiple, ulcers.3, 4, 7 Atypical presentations have been described in isolated cases, such as psoriasiform lesions, leonine facies, figured macules, papulovesicular lesions.3, 17 The aleukemic form is described as diffuse and papulonodular.6 More than 80% of the skin lesions are asymptomatic, few patients report pain or pruritus.4 The location and distribution also do not correlate with any specific cell type of leukemia cutis;10, 12 however, some authors associate the generalized conditions with acute forms of leukemia, while solitary, clustered, or dispersed lesions may be seen in chronic or acute forms.3 The dynamics of the appearance of infiltrations are also related to the type of leukemia, with the ones with rapid onset, in outbreaks, being associated with acute forms, while the ones with gradual onset are associated with chronic forms.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Cutaneous plasmacytomas are associated with all immunoglobulin classes, with the exception of IgE, and those related to IgG are the most frequently observed.23\nThe most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The most representative clinical form is isolated, smooth, rounded erythematous-violaceous nodules (Fig. 4), but there have been descriptions of flesh-colored nodules in rare cases.26 There is no difference in the clinical picture according to the immunoglobulin involved.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Lesion morphology did not correlate with survival in one case series.28\nFigure 5.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34\nFigure 6.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Nodules are often present (Fig. 5) in up to 60% of cases, but macules, patches, and plaques can also occur.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The secondary CD30+ anaplastic cutaneous lymphoma (Fig. 6) is more often characterized by papules and nodules, has a higher frequency of B symptoms, and has a worse prognosis, with higher mortality and shorter five-year survival.34.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 6,
    "claims_count": 84,
    "images_downloaded": 6,
    "tables_filtered": 61
  }
}